![Hilary Malone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hilary Malone
Direttore/Membro del Consiglio presso
HANSA BIOPHARMA AB
Profilo
Hilary Malone is currently Chief Executive Officer at CorriXR Therapeutics Inc. since 2026, Independent Director at Hansa Biopharma AB since 2021, and Venture Partner at Boston Millennia Partners.
Former roles include Director at Inhibikase Therapeutics, Inc. from 2016 to 2019, Chief Operating Officer & Executive Vice President at Valo Health, Inc. from 2020 to 2021, Chief Regulatory & Compliance Officer at Reata Pharmaceuticals, Inc. from 2011 to 2012, Chief Regulatory Officer & Senior Vice President at Sanofi, Inc., and Chief Operating Officer at Valo Health LLC from 2020 to 2024.
Education includes undergraduate and doctorate degrees from the University of Dundee.
Posizioni attive di Hilary Malone
| Società | Posizione | Inizio |
|---|---|---|
| HANSA BIOPHARMA AB | Direttore/Membro del Consiglio | 12/05/2021 |
Boston Millennia Partners
 Boston Millennia Partners Investment ManagersFinance BMP invests in companies located in the United States with revenue of USD 1 - 20 million and an enterprise value of less than USD 50 million. The firm focuses on the healthcare, business services and information technology sectors. It provides financing for early and growth stage capital transactions with an investment size of USD 0.1 - 3 million. The firm makes follow on investments and acts as a lead investor. | Investitore di Private Equity | - |
Corrixr Therapeutics Inc.
 Corrixr Therapeutics Inc. Packaged SoftwareTechnology Services Operates as a biotherapeutics development company that develops novel IP-protected in vivo gene editing therapeutic platform technology | Amministratore Delegato | 02/06/2026 |
Precedenti posizioni note di Hilary Malone
| Società | Posizione | Fine |
|---|---|---|
Valo Health LLC
 Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Direttore operativo | 18/11/2024 |
Valo Health, Inc.
 Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Direttore operativo | 01/09/2021 |
| INHIBIKASE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/01/2019 |
Sanofi, Inc.
 Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | - |
| REATA PHARMACEUTICALS, INC. | Consigliere Generale | - |
Formazione di Hilary Malone
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
11
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
Valo Health, Inc.
Valo Health, Inc. Financial ConglomeratesFinance Operates as a development stage company | Finance |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
Boston Millennia Partners
Boston Millennia Partners Investment ManagersFinance BMP invests in companies located in the United States with revenue of USD 1 - 20 million and an enterprise value of less than USD 50 million. The firm focuses on the healthcare, business services and information technology sectors. It provides financing for early and growth stage capital transactions with an investment size of USD 0.1 - 3 million. The firm makes follow on investments and acts as a lead investor. | Finance |
University Of Dundee
 University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sanofi, Inc.
Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Valo Health LLC
Valo Health LLC Packaged SoftwareTechnology Services Develops opal computational drug development software platform | Technology Services |
Corrixr Therapeutics Inc.
Corrixr Therapeutics Inc. Packaged SoftwareTechnology Services Operates as a biotherapeutics development company that develops novel IP-protected in vivo gene editing therapeutic platform technology | Technology Services |
